ArticleBMC cancer2023

Downregulation of TAB182 promotes cancer stem-like cell properties and therapeutic resistance in triple-negative breast cancer cells.

Huan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.